Lipid nanoparticles have shown success in targeting major organs such as the liver, spleen, and lungs, but crossing the blood-brain barrier (BBB) remains a major challenge. Effective brain-targeted delivery systems are essential for advancing gene therapy for neurological diseases but remain limited by low transport efficiency and poor nucleic acid stability. Here, we report a library of ionizable lipids based on the tetrahydroisoquinoline structure of protoberberine alkaloids, designed to improve BBB penetration via dopamine D3 receptor-mediated endocytosis. These nanoparticles offer three key advantages: enhanced brain uptake, improved nucleic acid stability through poly(A) self-assembly, and minimal immunogenicity with inherent neuroprotective properties. In murine models, they demonstrate therapeutic potential in Alzheimer’s disease, glioma, and cryptococcal meningitis. This berberine-inspired delivery system integrates precise receptor targeting with nucleic acid stabilization, offering a promising platform for brain-targeted therapeutics.
Despite advances in active drug targeting for blood-brain barrier penetration, two key challenges persist: first, attachment of a targeting ligand to the drug or drug carrier does not enhance its brain biodistribution; and second, many brain diseases are intricately linked to microcirculation disorders that significantly impede drug accumulation within brain lesions even after they cross the barrier. Inspired by the neuroprotective properties of vinpocetine, which regulates cerebral blood flow, we propose a molecular library design centered on this class of cyclic tertiary amine compounds and develop a self-enhanced brain-targeted nucleic acid delivery system. Our findings reveal that: (i) vinpocetine-derived ionizable-lipidoid nanoparticles efficiently breach the blood-brain barrier; (ii) they have high gene-loading capacity, facilitating endosomal escape and intracellular transport; (iii) their administration is safe with minimal immunogenicity even with prolonged use; and (iv) they have potent pharmacologic brain-protective activity and may synergize with treatments for brain disorders as demonstrated in male APP/PS1 mice.
Rosemary (Rosmarinus officinales L. (Labiatae)) is one of the major economic crops in the world, and rosemary essential oil (REO) is one of the top products derived from rosemary and has excellent commercial prospects. Many factors affect the yield of REO extracted by hydrodistillation (HY). This study was proposed to identify and analyze these factors to maximize the yield of essential oils and reduce the cost. First, two different single‐factor extraction experiments were conducted, (1) adding NaCl and (2) using various organs of the plant, to determine the influence of each factor on the oil yield. Based on single‐factor experiments, the orthogonal experiments (L9, 33) were designed to determine the optimal conditions for the extraction of rosemary oil. Meanwhile, the kinetic extraction analysis of the test data was carried out. The results revealed that the highest oil yield was achieved when rosemary leaves were crushed to 2 cm, the ratio of water to the material was 1:3, and NaCl concentration was 5%. A simple first‐order kinetic model has also proved to be an acceptable general choice and allows to predict the output of extraction operations overtime accurately and robustly in practice. This study provides a reference scheme for using hydrodistillation to extract rosemary essential oil.
25 April 2023 in Sensors and Actuators A: Physical